{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-272286","form_type":"8-K","ticker":"FDMT","cik":"0001650648","company_name":"4D Molecular Therapeutics, Inc.","filed_at":"2025-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.046442+00:00","generated_at":"2026-05-16T23:05:15.360687+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"4D Molecular Therapeutics raises ~$93.3M net in public offering of common stock and pre-funded warrants","bullets":["Sold 8,385,809 shares at $10.51/share and 1,128,949 pre-funded warrants at $10.5099 each.","Net proceeds approximately $93.3M after underwriting discounts and estimated expenses.","Offering closed on November 7, 2025; insiders subject to lock-up until January 6, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-272286","json":"https://secwatch.observer/filing/0001193125-25-272286.json","markdown":"https://secwatch.observer/filing/0001193125-25-272286.md","text":"https://secwatch.observer/filing/0001193125-25-272286.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650648/000119312525272286/0001193125-25-272286-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650648/000119312525272286/d89818d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:05:15.360687+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}